Your session is about to expire
← Back to Search
Aromatherapy for Postoperative Care in Knee Replacement
Study Summary
This trial tests if aromatherapy may reduce post-op anxiety, pain, opioid use & nausea in total knee replacement patients.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does the research extend to minors, or is it limited to adults?
"In order to be eligible for this clinical trial, the applicant must fall within the age range of 18-80."
To what extent do applicants need to meet certain criteria in order to be enrolled in this medical experiment?
"Qualified participants in this experiment must have received a total knee arthroplasty and be between 18-80 years old. A maximum of 30 people will be accepted into the study."
What is the current size of the participant pool for this clinical experiment?
"Affirmative, the data hosted on clinicaltrials.gov indicates that this study is still seeking patients to participate in its research. This trial was first published on October 3rd 2023 and has since been updated once more as of October 27th 2023. 30 participants are needed from 1 medical site."
Are there any open enrolment opportunities for this trial?
"Affirmative, the information shared on clinicaltrials.gov states that this medical research is actively searching for participants. The initial post date was October 3rd 2023 and it has since been updated as of October 27th 2023. This trial necessitates 30 patients to be recruited from a single site."
What are the main goals that this research endeavor is striving to accomplish?
"The primary assessment of this medical trial is the change in anxiety level before and after surgery. Secondary objectives include an evaluation of depression levels, average opioid consumption post-operatively, and symptom distress related to opioids. These will be measured pre-procedure, post anesthesia care unit (PACU), post operative day 1 (POD1), POD2, POD3, and on day 7 with various scales including PROMIS Depression Short Form 8a and Opioid Related Symptom Distress Scale (ORSDS)."
Share this study with friends
Copy Link
Messenger